Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC).

Scallet AC, Uemura E, Andrews A, Ali SF, McMillan DE, Paule MG, Brown RM, Slikker W Jr.

Brain Res. 1987 Dec 8;436(1):193-8.

PMID:
2825925
[PubMed - indexed for MEDLINE]
2.

Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems.

Landfield PW, Cadwallader LB, Vinsant S.

Brain Res. 1988 Mar 8;443(1-2):47-62.

PMID:
2834017
[PubMed - indexed for MEDLINE]
3.

Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain.

Ali SF, Newport GD, Scallet AC, Gee KW, Paule MG, Brown RM, Slikker W Jr.

Neurotoxicology. 1989 Fall;10(3):491-500.

PMID:
2576303
[PubMed - indexed for MEDLINE]
4.

Chronic marijuana smoke exposure in the rhesus monkey. IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats.

Ali SF, Newport GD, Scallet AC, Paule MG, Bailey JR, Slikker W Jr.

Pharmacol Biochem Behav. 1991 Nov;40(3):677-82.

PMID:
1666927
[PubMed - indexed for MEDLINE]
5.

NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).

National Toxicology Program.

Natl Toxicol Program Tech Rep Ser. 1996 Nov;446:1-317.

PMID:
12594529
[PubMed - as supplied by publisher]
Free Article
6.
7.

Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.

Holson RR, Ali SF, Scallet AC, Slikker W Jr, Paule MG.

Neurotoxicology. 1989 Fall;10(3):605-19.

PMID:
2576305
[PubMed - indexed for MEDLINE]
8.

Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.

Kolb B, Gorny G, Limebeer CL, Parker LA.

Synapse. 2006 Nov;60(6):429-36.

PMID:
16881072
[PubMed - indexed for MEDLINE]
10.

Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.

Lindamood C 3rd, Colasanti BK.

J Pharmacol Exp Ther. 1981 Nov;219(2):580-4.

PMID:
6270316
[PubMed - indexed for MEDLINE]
11.

Large-scale analysis of gene expression changes during acute and chronic exposure to [Delta]9-THC in rats.

Kittler JT, Grigorenko EV, Clayton C, Zhuang SY, Bundey SC, Trower MM, Wallace D, Hampson R, Deadwyler S.

Physiol Genomics. 2000 Sep 8;3(3):175-85.

PMID:
11015613
[PubMed - indexed for MEDLINE]
12.

Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.

Lindamood C 3rd, Colasanti BK.

J Pharmacol Exp Ther. 1980 May;213(2):216-21.

PMID:
6245205
[PubMed - indexed for MEDLINE]
13.

Effects of daily administration of tetrahydrocannabinol on rat preovulatory follicles. A quantitative electron-microscopic analysis.

Zoller LC, Carr K.

Acta Anat (Basel). 1988;131(4):265-70.

PMID:
2837037
[PubMed - indexed for MEDLINE]
14.

Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog.

Revuelta AV, Cheney DL, Costa E, Lander N, Mechoulam R.

Brain Res. 1980 Aug 18;195(2):445-52.

PMID:
6249445
[PubMed - indexed for MEDLINE]
15.

Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.

Nava F, Carta G, Colombo G, Gessa GL.

Neuropharmacology. 2001 Sep;41(3):392-9.

PMID:
11522331
[PubMed - indexed for MEDLINE]
16.

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.

Romero J, Berrendero F, Manzanares J, Pérez A, Corchero J, Fuentes JA, Fernández-Ruiz JJ, Ramos JA.

Synapse. 1998 Nov;30(3):298-308.

PMID:
9776133
[PubMed - indexed for MEDLINE]
17.

Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat.

Whitlow CT, Freedland CS, Porrino LJ.

Drug Alcohol Depend. 2003 Aug 20;71(2):169-77.

PMID:
12927655
[PubMed - indexed for MEDLINE]
18.

Cannabinoids and the hippocampal glucocorticoid receptor: recent findings and possible significance.

Eldridge JC, Murphy LL, Landfield PW.

Steroids. 1991 May;56(5):226-31. Review.

PMID:
1652167
[PubMed - indexed for MEDLINE]
19.

Effects of delta-9-tetrahydrocannabinol on sensory evoked hippocampal activity in the rat: principal components analysis and sequential dependency.

Hampson RE, Foster TC, Deadwyler SA.

J Pharmacol Exp Ther. 1989 Dec;251(3):870-7.

PMID:
2557421
[PubMed - indexed for MEDLINE]
20.

Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.

Carta G, Nava F, Gessa GL.

Brain Res. 1998 Oct 26;809(1):1-4.

PMID:
9795096
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk